Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Equity (Details)

v3.22.2.2
Shareholders' Equity (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 4 Months Ended 5 Months Ended 9 Months Ended
Oct. 12, 2020
Oct. 31, 2022
Oct. 31, 2021
Jun. 11, 2021
Oct. 31, 2021
Oct. 31, 2022
Jan. 31, 2022
Jan. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Common stock issued             133,258,027 4,000,000
Number of warrants to purchase additional common shares   45,667,000   705,882   45,667,000   705,882
Common shares authorized               1,000,000,000
Preferred shares authorized   10,000,000       10,000,000    
Common stock par value   $ 0.0001       $ 0.0001   $ 0.01
Common stock shares outstanding             133,258,027 4,000,000
Fair value adjustment of warrants $ 7,400 $ (9,128) $ 36,838 $ (900) $ 19,723 $ (26,080)    
Common stock repurchased, number of shares   645,428            
Cost of common stock repurchased   $ 1,400            
Class A Common Stock                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Common stock issued   164,316,842       164,316,842   3,840,000
Common shares authorized   375,000,000       375,000,000 375,000,000 800,000,000
Common stock par value   $ 0.0001       $ 0.0001 $ 0.0001  
Common stock shares outstanding   164,316,842       164,316,842   3,840,000
Increase (decrease) in earnings attributable to common stockholders (5,900)              
Class B Common Stock                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Common stock issued               160,000
Common shares authorized               200,000,000
Common stock shares outstanding               160,000
Net increase in value of participation rights 13,300              
Increase (decrease) in earnings attributable to common stockholders $ 5,900              
Class C Common Stock                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Common shares authorized   3,840,000       3,840,000